Skip to main content

Table 2 Comparison between pleural and serum IL-33 levels in all studied groups, tuberculous, malignant, parapneumonic and transudative groups

From: Diagnostic role of interleukin -33 in the differentiation of pleural effusions especially tuberculous and malignant effusions

Types of pleural effusion

Range

Mean (ng/l)

Paired “t.”

P

Pleural IL-33 of all studied group

6.44–23.95

14.14 ± 6.491

2.7

0.01 (S)*

Serum IL-33 of all studied group

5.23–20.32

12.06 ± 5.290

Tuberculous N = 36

Pleural IL-33

21.00–23.95

22.5 ± 0.90

22.3

< 0.001 (HS)**

Serum IL-33

12.46–15.11

13.9 ± 0.85

 

Malignant N = 33

Serum IL-33

15.21–20.32

13.5 ± 1.98

10.5

< 0.01 (S)*

Pleural IL-33

10.32–17.32

11.9 ± 2.35

 

Parapneumonic N = 24

Pleural IL-33

6.44–8.43

7.33 ± 0.72

15.5

< 0.001 (HS)**

Serum IL-33

5.23–7.21

6.22 ± 0.76

 

Transudative N = 24

Pleural IL-33

7.12–8.21

7.53 ± 0.38

10.5

< 0.001 (HS)**

Serum IL-33

5.38–6.78

6.10 ± 0.42

 
  1. TST Tuberculin Skin Test *S significant, **HS highly significant
  2. Shows that the pleural IL-33 level is significantly higher than the serum IL-33 level in all studied groups. Pleural IL-33 is significantly higher than the serum level in tuberculous, parapneumonic, and transudative groups; while serum IL-33 is significantly higher than the pleural level in the malignant group